Maintenance of Response to Risankizumab in Patients With Psoriatic Arthritis: A 5-Year Analysis of the KEEPsAKE 1 and 2 Trials. J of Skin 2025, 9 (6), s691. https://doi.org/10.25251/pwq1v445.